EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 14 filers reported holding EVOKE PHARMA INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | – | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | – | 500 | +2172.7% | 0.00% | – |
| Q1 2016 | $0 | – | 22 | +266.7% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 6 | -99.7% | 0.00% | – |
| Q1 2014 | $17,000 | – | 2,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 33,165 | $29,000 | 0.02% |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 400,000 | $344,000 | 0.00% |
| A.R.T. Advisors, LLC | 36,954 | $32,000 | 0.00% |
| NORTHERN TRUST CORP | 33,997 | $29,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 199,678 | $171,000 | 0.00% |
| CITIGROUP INC | 500 | $0 | 0.00% |
| MORGAN STANLEY | 1,450 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 36,700 | $32,000 | 0.00% |
| BlackRock Inc. | 54,940 | $47,000 | 0.00% |